• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Belviq and formulary access

Quote












Anonymous said:
$120 co-pays shouldn't be a problem. Now get out there and sell!
Click to expand...

That's just a stupid thing to say. 35-45 at the upper limit. People who want to lose weight will have no trouble at all paying this OOP. I had this conversation the other night at a social event and 10 out of 12 women said they would have no problem shelling out 100.00/month to drop 10-15 lbs over 6 months
 




Anonymous said:
That's just a stupid thing to say. 35-45 at the upper limit. People who want to lose weight will have no trouble at all paying this OOP. I had this conversation the other night at a social event and 10 out of 12 women said they would have no problem shelling out 100.00/month to drop 10-15 lbs over 6 months
Click to expand...

BS. First, tier 3 is still a long shot for most PBM’s and payers, as most PBM will offer zero coverage. Look at any of the other weight loss drugs. Almost none had/have PBM coverage or formulary coverage from payers. Not sure why you think Belviq will be any different...This will be primarily a cash pay drug.

I’m guessing you probably did your ‘poll’ with the wrong women unless they ranged in weight from 200 to 300 lbs. 5% of 200 lbs is 10 pounds and 5% of 300 is 15 pounds so you must have been hanging with some real fatties if 10 to 15 pounds is six months was what you were talking about. Also remember you need to be morbidly obese and/or have commodities based on the label. So unless you meet each criterion even plans that provide tier 3 coverage will force doctors to stick to the label, there will be not prior auth for off label usage for this drug. So the 5’4 140 lb women who is looking to slim down a bit will not get coverage for this drug, and my guess is most physicians will not write this drug off label, even if the patients is willing to pay cash. This is not the fen-Phen days! The doc’s do not want to get burned again.
 




Anonymous said:
BS. First, tier 3 is still a long shot for most PBM’s and payers, as most PBM will offer zero coverage. Look at any of the other weight loss drugs. Almost none had/have PBM coverage or formulary coverage from payers. Not sure why you think Belviq will be any different...This will be primarily a cash pay drug.

I’m guessing you probably did your ‘poll’ with the wrong women unless they ranged in weight from 200 to 300 lbs. 5% of 200 lbs is 10 pounds and 5% of 300 is 15 pounds so you must have been hanging with some real fatties if 10 to 15 pounds is six months was what you were talking about. Also remember you need to be morbidly obese and/or have commodities based on the label. So unless you meet each criterion even plans that provide tier 3 coverage will force doctors to stick to the label, there will be not prior auth for off label usage for this drug. So the 5’4 140 lb women who is looking to slim down a bit will not get coverage for this drug, and my guess is most physicians will not write this drug off label, even if the patients is willing to pay cash. This is not the fen-Phen days! The doc’s do not want to get burned again.
Click to expand...

Then you should just go away and stop wasting your time and energy trying to argue your points. If you are so confident in your over-inflated opinions-- go with God. You should get your clinical data squared away on the Belviq trials though. Really - if you're going to try and come off a soooo informed an such an expert, due the work to at least inform yourself on the facts of the trials...all of them!
 




Anonymous said:
Then you should just go away and stop wasting your time and energy trying to argue your points. If you are so confident in your over-inflated opinions-- go with God. You should get your clinical data squared away on the Belviq trials though. Really - if you're going to try and come off a soooo informed an such an expert, due the work to at least inform yourself on the facts of the trials...all of them!
Click to expand...

5%
 








meaning half did NOT - that doubles the cost for a benefit. Imagine a plan evaluating a statin or antihypertensive that only works HALF the time. Efficacy is not there and will continue to be our achilles.
 




Anonymous said:
Approx 50% lost 5-8%... Go ask any endocrinologist the impact of this on an obese persons metabolic and CV health! They'll tell you it's a life saving change! Of course more will be better... But 5-8% is life-saving !! AND...WORTH EVERY CENT
Click to expand...

The bariatric community already came out in the analysts’ reports saying that 5% to 8% weight loss is negligible at best versus the risks, versus the cost, versus the alternatives. Read a little more, maybe you will learn something. Again Phentermine, along with others are still on the market and has more robust weight loss, so if 5% to 8% was ‘life saving’ they would already be on that!

Keep hope alive, dreamer. Reality will set in, in just a few months.
 




















Top Bottom
Back
Quote